Terms: = Thyroid cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
11 results:
1. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
[TBL] [Abstract] [Full Text] [Related]
2. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
[TBL] [Abstract] [Full Text] [Related]
3. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.
Murai H; Kodama T; Maesaka K; Tange S; Motooka D; Suzuki Y; Shigematsu Y; Inamura K; Mise Y; Saiura A; Ono Y; Takahashi Y; Kawasaki Y; Iino S; Kobayashi S; Idogawa M; Tokino T; Hashidate-Yoshida T; Shindou H; Miyazaki M; Imai Y; Tanaka S; Mita E; Ohkawa K; Hikita H; Sakamori R; Tatsumi T; Eguchi H; Morii E; Takehara T
Hepatology; 2023 Jan; 77(1):77-91. PubMed ID: 35567547
[TBL] [Abstract] [Full Text] [Related]
4. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior.
Euscher ED; Bassett R; Duose DY; Lan C; Wistuba I; Ramondetta L; Ramalingam P; Malpica A
Am J Surg Pathol; 2020 Apr; 44(4):429-443. PubMed ID: 31725471
[TBL] [Abstract] [Full Text] [Related]
5. Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of ctnnb1-mutated medulloblastomas.
Surun A; Varlet P; Brugières L; Lacour B; Faure-Conter C; Leblond P; Bertozzi-Salomon AI; Berger C; André N; Sariban E; Raimbault S; Prieur F; Desseigne F; Zattara H; Guimbaud R; Polivka M; Delisle MB; Vasiljevic A; Maurage CA; Figarella-Branger D; Coulet F; Guerrini-Rousseau L; Alapetite C; Dufour C; Colas C; Doz F; Bourdeaut F
Neuro Oncol; 2020 Jan; 22(1):128-138. PubMed ID: 31504825
[TBL] [Abstract] [Full Text] [Related]
6. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/ctnnb1 axis and activating Wnt/β-catenin pathway.
Tan A; Li Q; Chen L
Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx].
Bonassi S; Prinzi G; Lamonaca P; Russo P; Paximadas I; Rasoni G; Rossi R; Ruggi M; Malandrino S; Sánchez-Flores M; Valdiglesias V; Benassi B; Pacchierotti F; Villani P; Panatta M; Cordelli E
BMC Complement Altern Med; 2018 Jan; 18(1):22. PubMed ID: 29357859
[TBL] [Abstract] [Full Text] [Related]
8. The first postoperative-stimulated serum thyroglobulin is a prognostic factor for thyroid microcarcinomas.
Amui IO; Tagliarini JV; Castilho EC; Marques MA; Kiy Y; Corrente JE; Mazeto GMFS
Braz J Otorhinolaryngol; 2019; 85(1):37-42. PubMed ID: 29157630
[TBL] [Abstract] [Full Text] [Related]
9. thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular cancer.
Puliga E; Min Q; Tao J; Zhang R; Pradhan-Sundd T; Poddar M; Singh S; Columbano A; Yu J; Monga SP
Am J Pathol; 2017 Nov; 187(11):2473-2485. PubMed ID: 28807594
[TBL] [Abstract] [Full Text] [Related]
10. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM
J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316
[TBL] [Abstract] [Full Text] [Related]
11. Second opinion in thyroid fine-needle aspiration biopsy by the Bethesda system.
Park JH; Kim HK; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Endocr J; 2012; 59(3):205-12. PubMed ID: 22156326
[TBL] [Abstract] [Full Text] [Related]
